000
| 01793cam 2200313za 4500 |
---|
001 | 9.850234 |
---|
003 | CaOODSP |
---|
005 | 20221107154118 |
---|
007 | cr ||||||||||| |
---|
008 | 180117s2017 onca #ob f000 0 eng d |
---|
020 | |a978-0-660-24572-0 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aHP40-206/2018E-PDF |
---|
245 | 00|aReport on the enhanced surveillance of antimicrobial-resistant gonorrhea |h[electronic resource] : |bresults from the 2014 pilot. |
---|
260 | |aOttawa : |bPublic Health Agency of Canada, Infectious Disease Prevention and Control Branch, |c2017. |
---|
300 | |ai, 32 p. : |bill. |
---|
500 | |a"September 2017." |
---|
500 | |aTitle from cover. |
---|
500 | |a"Protecting and empowering Canadians to improve their health"--Cover. |
---|
500 | |aIssued also in French under title: Rapport sur le système de surveillance accrue de la résistance de la gonorrhée aux antimicrobiens : résultats de la phase pilote de 2014. |
---|
504 | |aIncludes bibliographical references. |
---|
520 | |a"Gonorrhea is the second most common bacterial sexually transmitted infection (STI) in Canada with over 16,000 cases annually. Antimicrobial resistance (AMR) in Neisseria gonorrhoeae (N. gonorrhoeae) is a serious threat to effective treatment of gonococcal infections"--Executive summary, p. 2. |
---|
692 | 07|2gccst|aSexually transmitted diseases |
---|
692 | 07|2gccst|aInfectious diseases |
---|
692 | 07|2gccst|aMedical research |
---|
710 | 2 |aPublic Health Agency of Canada. |bInfectious Disease Prevention and Control Branch. |
---|
775 | 08|tRapport sur le système de surveillance accrue de la résistance de la gonorrhée aux antimicrobiens |w(CaOODSP)9.850235 |
---|
856 | 40|qPDF|s731 KB|uhttps://publications.gc.ca/collections/collection_2018/aspc-phac/HP40-206-2018-eng.pdf |
---|